Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.35 |
| ▸ | XDH | P47989 | 1/20 | 0.32 |
| ▸ | CCR8 | P51685 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3208944 | 0.76 | — | — | |
| SCHEMBL8663414 | 0.76 | CCR8 (0.37) | CCR8KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL6955683 | 0.75 | GABRA1 (0.37) | GABRA1GABRB2CCR8KMT2AKDM4E | |
| SCHEMBL8718496 | 0.72 | GABRA1 (0.48) | GABRA1GABRB2GAAKMT2AMEN1 | |
| SCHEMBL10427969 | 0.72 | KMT2A (0.33) | KMT2A | |
| SCHEMBL9681824 | 0.70 | CA12 (0.33) | CCR8KMT2A | |
| SCHEMBL4798157 | 0.70 | KEAP1 (0.37) | GAAKMT2AMAPTKDM4EALDH1A1 | |
| SCHEMBL1655686 | 0.70 | GABRA1 (0.36) | GABRA1GABRB2POLB | |
| Hydrochloric Acid SCHEMBL10818767 | 0.69 | KEAP1 (0.36) | GAAKMT2AMAPTKDM4EALDH1A1 | |
| SCHEMBL10818764 | 0.69 | KMT2A (0.32) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11352447-B2 | Gellan gum hydrogels, preparation, methods and uses thereof | Stemmatters, Biotecnologia e Medicina Regenerativa, S.A. (PT) | 2022-06-07 | — | — | US | disclosed |
| US-20190330384-A1 | GELLAN GUM HYDROGELS, PREPARATION, METHODS AND USES THEREOF | Stemmatters, Biotecnologia e Medicina Regenerativa, S.A. (PT) | 2019-10-31 | — | — | US | disclosed |
| EP-3433283-A1 | GELLAN GUM HYDROGELS, PREPARATION, METHODS AND USES THEREOF | Stemmatters, Biotecnologia e Medicina Regenerativa, S.A. (PT) | 2019-01-30 | — | — | EP | disclosed |
| CN-109153734-A | Gellan gum hydrogel, preparation method and application thereof | 斯泰玛特斯，生物技术药物改造有限公司 | 2019-01-04 | — | — | CN | disclosed |
| CN-107266359-A | A kind of chelating agent, its synthetic method and purposes and the chelate containing the chelating agent | 原子高科股份有限公司 | 2017-10-20 | — | — | CN | disclosed |
| WO-2017163222-A1 | GELLAN GUM HYDROGELS, PREPARATION, METHODS AND USES THEREOF | Stemmatters, Biotecnologia e Medicina Regenerativa, S.A. (PT) | 2017-09-28 | — | — | WO | disclosed |
| US-8334320-B2 | Methods for chelation therapy | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2012-12-18 | — | — | US | disclosed |
| US-20100310460-A1 | COMPOSITIONS AND METHODS FOR CHELATION THERAPY | LIU GANG | 2010-12-09 | — | — | US | disclosed |
| US-7728038-B2 | Methods for chelation therapy | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2010-06-01 | — | — | US | disclosed |
| US-20060030619-A1 | Compositions and methods for chelation therapy | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2006-02-09 | — | — | US | disclosed |
| US-5814614-A | Substituted glucose compounds for toxic metal ion removal from the body | KRUCK THEO P A (CA) | 1998-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100310460-A1 | COMPOSITIONS AND METHODS FOR CHELATION THERAPY | SOST, SOD3, HIF1AN | GABRA1 4702/4885GABRB2 4663/4885XDH 499/4885 |
| US-20060030619-A1 | Compositions and methods for chelation therapy | SOST, SOD3, HIF1AN | GABRA1 4702/4885GABRB2 4663/4885XDH 499/4885 |
| US-11352447-B2 | Gellan gum hydrogels, preparation, methods and uses thereof | GYPA, CD44, ALG1 | GABRA1 1397/4885GABRB2 1580/4885XDH 3218/4885 |
| US-20190330384-A1 | GELLAN GUM HYDROGELS, PREPARATION, METHODS AND USES THEREOF | GYPA, CD44, ALG1 | GABRA1 1397/4885GABRB2 1580/4885XDH 3218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.